Meeting
2023 ASCO Genitourinary Cancers Symposium
Creatinine to cystatin C ratio and mortality in renal cell carcinoma.
Authors
Benjamin Schmeusser
Department of Urology, Emory University School of Medicine, Atlanta, GA
Benjamin Schmeusser , Adil Ali , Dattatraya H Patil , Eric Midenberg , Reza Nabavizadeh , Kenneth Ogan , Viraj A. Master
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 697)
DOI
10.1200/JCO.2023.41.6_suppl.697
Abstract #
697
Poster Bd #
J10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Is pathological upstaging to T3a renal cell carcinoma associated with a similar prognosis to non-upstaged pathologic T3a disease? A multicenter analysis.
First Author: Ryan Nasseri
Poster
2022 ASCO Annual Meeting
Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).
First Author: Naomi B. Haas
Poster
2020 Genitourinary Cancers Symposium
Multicenter comparison of outcomes for clinical and pathologic T3a renal cell carcinoma.
First Author: Aaron Bradshaw
Poster
2023 ASCO Genitourinary Cancers Symposium
Preoperative c-reactive protein and risk of major complications and mortality outcomes in patients undergoing surgery for renal cell carcinoma.
First Author: Franklin Liu